隨著世界各國預期壽命持續延長，糖尿病的患病率卻不斷增加。糖尿病對社會帶來的負擔不只有醫療支出，尚包含對於生產力的影響，以及由糖尿病引起的併發症所導致的額外治療費用和損失，也應當被考量。如何客觀的從總體經濟、社會的角度衡量疾病所帶來的損失，進而比較糖尿病發病前後的損失差異，以及各年齡層、不同國家間該疾病所造成的負擔差異。研究結果將有助於公共衛生政策的制定參考。
本研究運用失能調整人年(Disability-adjusted life years, DALYs)與人力資本法(Human Capital Approach, HCA)做為評估方法，衡量2021年糖尿病對台灣和韓國民眾健康與經濟的影響。失能調整人年為哈佛大學與世界衛生組織提出的一種衡量健康損失的方法，也是目前衡量疾病損失的主流方法之一，優點在於評估方法簡單快速且易於比較，缺點為計算上通常只設定單一死因，並不是由診間實際測量。經濟損失方面，本研究使用人力資本法，從社會角度衡量疾病的影響。
研究發現:台灣每千人健康損失男性約為7.79DALYs，女性約為5.9DALYs。南韓每千人健康損失男性約為7.13DALYs，女性約為3.69DALYs。經濟損失以人力資本法衡量。總永久性損失的部分，台灣男性為3.5億美元，佔GDP 0.048%；南韓約為5.1億美元，佔GDP比例為0.028%。總暫時性損失，台灣為0.32億美元，佔GDP 0.004%；南韓則是0.73億美元，佔GDP 0.004%。

To estimate the impact of noncommunicable diseases on the economy, this study utilizes disability-adjusted life years (DALYs) to measure health loss and applies the human capital approach (HCA) to calculate productivity loss. The findings indicate that in Taiwan, the health loss is approximately 7.79 DALYs per thousand individuals for males and 5.9 DALYs per thousand individuals for females. In South Korea, the corresponding estimations are approximately 7.13 DALYs per thousand individuals for males and 3.69 DALYs per thousand individuals for females. Total permanent productivity losses amount to 350 million USD for Taiwanese males (0.048% of GDP) and 356 million USD for Taiwanese females. In South Korea, the estimated permanent losses are 510 million USD (0.028% of GDP). Total temporary productivity losses in Taiwan are around 32 million USD (0.004% of GDP). Temporary productivity losses are approximately 73 million USD (0.004% of GDP) in South Korea.
The study reveals that the group of aged 55 to 59 years experiences the highest DALYs loss in Taiwan. Furthermore, as individuals got older, the impact of years of life lost becomes more pronounced in men compared to women, although women also experience a similar phenomenon. In Korea, the group of aged 50 to 54 years encounters the highest health effects or DALYs loss. These findings shed light on the policy implications on the prevention of noncommunicable diseases in Taiwan and South Korea.

Auld, M. C. (2002). Disentangling the effects of morbidity and life expectancy on labor market outcomes. Health Economics, 11 (6):471-483.

American Diabetes Association(2013). Economic costs of diabetes in the U.S. in 2012. Diabetes Care,36:1033-1046.

Animaw, W. and Y. Seyoum (2017). Increasing prevalence of diabetes mellitus in a developing country and its related factors.Plos One,12(11): e0187670.

Anders, H. J., et al. (2018).CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease.Nature Reviews Nephrology,14(6): 361-377.

Bhargava, A., Jamison, D. T., Lau, L. J., & Murray, C. J. (2001). Modeling the effects of health on economic growth. Journal of Health Economics,20(3):423-440.

Bhattarai, R. et al. (2019). The monetary burden of cysticercosis in Mexico. Plos Neglected Tropical Diseases, 13(7):e0007501.

Ben-Assuli O. (2022). Measuring the cost-effectiveness of using telehealth for diabetes management: a narrative review of methods and findings. International Journal of Medical Informatics,163:104764.

C. Daousi, I. F. Casson, G. V. Gill, I. A. Macfarlane, J. P. H. Wilding and J. H. Pinkney(2006). Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgraduate Medical Journal, 82 (966):280-284.

Caliendo, M. & Lee, W.-S.(2013). Fat chance! obesity and the transition from unemployment to employment. Economics & Human Biology,11(2):121-133.

Cervellati, M., & Sunde, U. (2013). Life expectancy, schooling, and lifetime labor supply: theory and evidence revisited. Econometrica, 81(5):2055-2086.

Connolly, M. P., Tashjian, C., Kotsopoulos, N., Bhatt, A. & Postma, M. J. (2017). A comparison of average wages with age-specific wages for assessing indirect productivity losses: analytic simplicity versus analytic precision. European Journal of Health Economics,18 (6):697-701.

Chen, S., Kuhn, M., Prettner, K. & Bloom, D. E. (2018). The macroeconomic burden of noncommunicable diseases in the United States: estimates and projections. Plos One,13 (11):0206702.

Cho SW, Kim SH, Kim YE, Yoon SJ, Jo MW. (2019)Estimating lifetime duration of diabetes by age and gender in the korean population using a markov model. Korean Medical Science,34(Suppl 1):e74.

C. Abbafati, K. M. Abbas, M. Abbasi, M. Abbasifard, M. Abbasi-Kangevari, H. Abbastabar, et al.(2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396(10258): 1204-1222.

Christofides, E. A. and N. Desai (2021). Optimal Early diagnosis and monitoring of diabetic kidney disease in type 2 diabetes mellitus: addressing the barriers to albuminuria testing. Journal of Primary Care and Community Health,12:21501327211003683.

David E. Bloom, David Canning, Jaypee Sevilla(2004).The effect of health on economic growth: a production function approach,World Development,32:1-13.

David W. Dunstan, Elena Vulikh, Neville Owen, Damien Jolley, Jonathan Shaw, Paul Zimmet(2006).Community center–based resistance training for the maintenance of glycemic control in adults with type 2 diabetes. Diabetes Care,29(12):2586-2591.

Drucker, D. J. (2020). Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications. Endocrine Reviews, 41 (3):457-470.

Espelt, A., Borrell, C., Roskam, A.J. et al.(2008). Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century. Diabetologia 51(11): 1971-1979.

Franco Sassi(2006). Calculating qalys, comparing qaly and daly calculations. Health Policy and Planning, 21(5):402-408

Fu, A. Z., et al. (2009). Health care and productivity costs associated with diabetic patients with acrovascular comorbid conditions. Diabetes Care 32(12): 2187-2192.

Feigl AB, Goryakin Y, Devaux M, Lerouge A, Vuik S, et al. (2019) The short-term effect of bmi, alcohol use, and related chronic conditions on labour market outcomes: a time-lag panel analysis utilizing european share dataset. Plos One,14(3): e0211940.

Harvard School of Public Health(‎1996)‎.The Global burden of disease : a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 the harvard school of public health on behalf of the world health organization and the world bank

Hwang, J. S., Tsauo, J. Y., & Wang, J. D. (1996). Estimation of expected quality adjusted survival by cross-sectional survey. Statistics in Medicine, 15(1):93-102.

Hwang, J. S., & Wang, J. D. (1999). Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies. Statistics in Medicine, 18(13):1627-1640.

Herquelot, E., Guéguen, A., Bonenfant, S., & Dray-Spira, R. (2011).Impact of diabetes on work cessation: data from the GAZEL cohort study. Diabetes Care,34 (6):1344-
1349.

Hanly, P., Koopmanschap, M. & Sharp, L. (2016). Valuing productivity costs in a changing macroeconomic environment: the estimation of colorectal cancer productivity costs using the friction cost approach. European Journal of Health Economics, 17(5):553-561.

Hanly, P., Ortega Ortega, M., Pearce, A. et al. (2023). Estimating global friction periods for economic evaluation: a case study of selected oecd member countries.Pharmacoeconomics.

James W. Anderson, Cyril W.C. Kendall & David J.A. Jenkins (2003) Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies, Journal of The American College of Nutrition, 22(5):331-339

Jonas, D. E., Russell, L. B., Chou, J. & Pignone, M. (2010). Willingness-to-pay to avoid the time spent and discomfort associated with screening colonoscopy. Health Economics,19(10):1193-1211.

Javanbakht, M. et al. (2011). Cost-of-illness analysis of type 2 diabetes mellitus in iran. Plos One, 6 (10):e26864.

Jo, C. (2014). Cost-of-illness studies: concepts, scopes, and methods. Clinical and Molecular Hepatology, 20(4):327337.

J. L. Liu, R. H. Bai, Z. L. Chai, M. E. Cooper, P. Z. Zimmet and L. Zhang(2022). Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990-2019 data. Diabetologia, 65: 1339-1352.

Keske, M. A., Clerk, L. H., Price, W. J., Jahn, L. A., & Barrett, E. J. (2009). Obesity blunts microvascular recruitment in human forearm muscle after a mixed meal. Diabetes Care, 32(9):1672-1677.

Kivimäki, M. et al. (2017). Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 12083 adults from 16 cohort studies from the USA and Europe. Lancet Public Health, 2 (6):e277-e285.

Kim, J., Yoon, S.-J. & Jo, M.-W. (2021). Estimating the disease burden of Korean type 2 diabetes mellitus patients considering its complications. Plos One, 16 (2): e0246635.

Kautzky-Willer, A., Leutner, M. & Harreiter, J. (2023). Sex differences in type 2 diabetes. Diabetologia, 66 (6): 986-1002.

Lee, H.-Y., Chen, Y.-H., Chiu, W.-T., Hwang, J.-S. & Wang, J.-D. (2010). Quality-adjusted life-years and helmet use among motorcyclists sustaining head injuries. American Journal of Public Health, 100 (1):165–170.

Lacroix, G., Laliberté‐Auger, F., Michaud, P. & Parent, D. (2021). The effect of college education on health and mortality: evidence from canada. Health Economics, 30 (S1):105–118.

Lim, S., Bae, J. H., Kwon, H.-S. & Nauck, M. A. (2021). COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nature Reviews Endocrinology,17(1):11-30.

Murray, Christopher J. L, Lopez, Alan D, World Health Organization, World Bank & Mauvais-Jarvis, F. (2017). Epidemiology of gender differences in diabetes and obesity. I:Biology of The Mammary Gland ,s. 3-8.

Nanda, M., Sharma, R., Mubarik, S. et al. (2022) Type-2 Diabetes mellitus (T2DM): Spatial-temporal patterns of incidence, mortality and attributable risk factors from 1990 to 2019 among 21 world regions. Endocrine,77:444-454.

Ohkubo, Y., Kishikawa, H., Araki, E., Miyata, T., Isami, S., Motoyoshi, S., Kojima, Y., Furuyoshi, N., & Shichiri, M. (1995). Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. DiabetesResearch and Clinical Practice, 28(2):103-117.

R. M. Solow(1965).A contribution to the theory of economic growth. Quarterly Journal of Economics,70:65-94.

Robine, J. M., Romieu, I. & Cambois, E. (‎1999)‎. Health expectancy indicators. Bulletin of The World Health Organization, 77 (‎2):181-185.

Rushby, J. F. and K. Hanson (2001). Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy and Planning 16(3): 326-331.

Raghupathi, V. & Raghupathi, W. (2020). The influence of education on health: an empirical assessment of OECD countries for the period 1995–2015. Archives of Public Health, 78 (1).

Ridhwan, M. M., Nijkamp, P., Ismail, A. & M.Irsyad, L. (2022). The effect of health on economic growth: a meta-regression analysis. Empirical Economics,63(6):s.3211-3251.

Roy, B., & Runa, S. A. (2022). SARS-CoV-2 infection and diabetes: pathophysiological mechanism of multi-system organ failure. World Journal of Virology, 11(5):252-274.

Sofia Carlsson, Niklas Hammar, Valdemar Grill, Jaakko Kaprio; Alcohol(2003) Consumption and the incidence of type 2 diabetes: a 20-year follow-up of the finnish twin cohort study. Diabetes Care ,26 (10): 2785-2790.

Shepard, B. D. (2019). Sex differences in diabetes and kidney disease: mechanisms and consequences. American Journal of Physiology-Renal Physiology, 317(2): F456-F462.

Shepard, B. D. (2019). Sex differences in diabetes and kidney disease: mechanisms and consequences. American Journal of Physiology-Renal Physiology,317 (2): F456-F462

Tramunt, B. et al. (2020). Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia, 63 (3):453-461.

Tomic, D. et al. (2022). Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study. Lancet Diabetes & Endocrinology, 10(11):795-803.

Tokita, J., et al. (2022). real world evidence and clinical utility of kidneyintelx on patients with early-stage diabetic kidney disease: interim results on decision impact and outcomes.Journal of Primary Care & Community Health 13: 21501319221138196.

Uk Prospective Diabetes Study Group (1998). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes,UKPDS 38. Bmj, 317 (7160): s. 703-713.

Yang JJ, Yu D, Wen W, et al. (2019). Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: a pooled analysis of more than 1 million participants.Jama Netw Open, 2(4):e192696.

Well, David N., (2007).Accounting for the effect of health on economic growth. Quarterly Journal of Economics,122(3):1265-1306

Wing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., & Look AHEAD Research Group (2011). Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care, 34(7):1481-1486.

Wilding, J. P. H. (2014). The importance of weight management in type 2 diabetes mellitus. International Journal of Clinical Practice, 68 (6): 682-691.

Wen, C. P. et al. (2017). Diabetes with early kidney involvement may shorten life expectancy by 16 years. Kidney international, 92 (2):388-396.

Zeckhauser, R., & Shepard, D. (1976). Where Now for Saving Lives? Law and Contemporary Problems, 40(4):5-45.